Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Jidong Hong"'
Autor:
Wei Zhang, Ruiyue Dang, Hongyi Liu, Luohuan Dai, Hongwei Liu, Abraham Ayodeji Adegboro, Yihao Zhang, Wang Li, Kang Peng, Jidong Hong, Xuejun Li
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-22 (2024)
Abstract Glioblastoma is a highly aggressive and malignant type of brain cancer that originates from glial cells in the brain, with a median survival time of 15 months and a 5-year survival rate of less than 5%. Regulated cell death (RCD) is the auto
Externí odkaz:
https://doaj.org/article/dcc44123b146446d8d401b1e37681eca
Autor:
Wenjun Cao, Luqi Xiong, Li Meng, Zhanzhan Li, Zhongliang Hu, Huo Lei, Jun Wu, Tao Song, Chao Liu, Rui Wei, Liangfang Shen, Jidong Hong
Publikováno v:
Heliyon, Vol 9, Iss 7, Pp e18310- (2023)
As many countries face an ageing population, the number of older patients with glioblastoma (GB) is increasing. Thus, there is an urgent need for prognostic models to aid in treatment decision-making and life planning. A total of 98 patients with iso
Externí odkaz:
https://doaj.org/article/3ddea2bf2e734146a5ddf440d0eb6437
Autor:
Qiongxuan Xie, Bin Xie, Ludi Ou, Min Wang, Ziqing Tang, Yuxiang He, Xiaoyu Yang, Jidong Hong, Zhiping Lyu, Rui Wei
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveCentral neurocytoma (CN) is a rare type of tumor that currently lacks an optimal treatment protocol. This study aimed to explore the clinical outcomes of CN in a cohort of 101 patients and identify prognostic factors associated with multiple
Externí odkaz:
https://doaj.org/article/35674766ada94d68a9a877b4a291e2e5
Autor:
Jidong Hong, Rui Wei, Du Tang, Chao Liu, Jun Wu, Ying Cao, Tao Song, Zhen Yang, Liangfang Shen, Ying Wang, Yining Xiang, Zhanzhan Li, Li Men, Qin Zhou, Lei Huo
Publikováno v:
Cancer Management and Research
Ying Cao,1,* Du Tang,1,* Yining Xiang,1 Li Men,2 Chao Liu,1 Qin Zhou,1 Jun Wu,3 Lei Huo,3 Tao Song,3 Ying Wang,4 Zhanzhan Li,1 Rui Wei,1 Liangfang Shen,1 Zhen Yang,1 Jidong Hong1 1Department of Oncology, Xiangya Hospital, Central South University, Ch
Publikováno v:
OncoTargets and Therapy. 13:7877-7885
Human endogenous retroviruses (HERVs) form an important part of the human genome, commonly losing their coding ability and exhibiting only rare expression in healthy tissues to promote the stability of the genome. However, overexpression of HERVs has
Publikováno v:
Translational Cancer Research
Background To evaluate the potential dosimetric gains of helical tomotherapy (HT) versus intensity-modulated radiotherapy (IMRT) and volume-modulated arc therapy (VMAT) for craniospinal axis irradiation (CSI) of medulloblastoma. Methods A total of 36
Autor:
Pei Liu, Gui Liu, Jidong Hong, Guihua Wang, Qian Zeng, Weibing Zhou, Qiongxuan Xie, Rui Wei, Yangqing Sun, Wen Chen, Ludi Ou
Publikováno v:
BioMed Research International, Vol 2020 (2020)
BioMed Research International
BioMed Research International
Purpose. Because of the poor prognosis for high-grade glioma (HGG) patients, it is important to increase the dose of the tumor to improve the efficacy while minimizing the dose of organs at risk (OARs). Thus, we evaluated the potential dosimetric gai
Autor:
Ritsuko Komaki, Y. Zhuang, Tommy Sheu, Lawrence B. Levy, Daniel R. Gomez, Ting Xu, John V. Heymach, Zhongxing Liao, Jidong Hong, Quynh-Nhu Nguyen
Publikováno v:
American Journal of Clinical Oncology. 41:46-52
Purpose We analyzed overall and disease-free survival (OS and DFS) after definitive (chemo)radiation for stage III non-small cell lung cancer with 2 statistical methods: Kaplan-Meier (KM) analysis, with diagnosis as index date, and conditional surviv
Autor:
Wen Chen, Xiaoyu Yang, Nian Jiang, Zijian Zhang, Jidong Hong, Yuxiang He, Junli Luo, Ying Liang, Rui Wei
Publikováno v:
Translational Cancer Research. 6:929-939
Autor:
Liangfang Shen, Jianghua Peng, Yiying Bian, Lei Huo, Jidong Hong, Huan Yang, Junfeng Li, Jun Fu, Rui Wei, Ying Wang, Li Meng
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
This study aimed to explore the effects of radiochemotherapy on the neurocognitive function of patients with high-grade gliomas (HGG). The mini-mental state examination (MMSE), Montreal Cognitive Assessment (MoCA), event-related potential P300 (ERP-P